Ensuring Viral Safety: Advanced Biopharmaceutical Manufacturing
As biologics manufacturing becomes increasingly sophisticated, ensuring product safety remains a top priority throughout development and production. Detecting potential viral contaminants requires technologies capable of identifying a wide range of known and unexpected threats with precision and confidence.
This video explores how Next Generation Sequencing (NGS) is transforming viral detection by providing a comprehensive view of genetic material within a sample. Follow the journey from raw sequencing data through advanced computational analysis, including quality control, filtering, sequence alignment, and species-level identification.
Discover how cloud-based technologies support secure, scalable, and traceable data processing while enabling highly sensitive analysis. Learn how curated reference databases and specialized bioinformatics workflows contribute to a robust approach for evaluating complex biological samples.
By combining advanced sequencing capabilities with modern computational tools, this approach offers new possibilities for supporting quality, consistency, and confidence across today's rapidly evolving biopharmaceutical manufacturing landscape.
Get unlimited access to:
Enter your credentials below to log in. Not yet a member of Pharmaceutical Online? Subscribe today.